(Q51875232)

15 April 2018

meta-analysis

0 references

title

Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. (English)

1 reference

15 April 2018

attention deficit hyperactivity disorder

1 reference

1 reference

Russell A Barkley

1

1 reference

15 April 2018

Thomas E Brown

series ordinal

2

1 reference

15 April 2018

publication date

1 November 2008

1 reference

15 April 2018

published in

C N S Spectrums

1 reference

15 April 2018

volume

13

1 reference

15 April 2018

issue

11

1 reference

15 April 2018

page(s)

977-984

1 reference

15 April 2018

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

The role of comorbid major depressive disorder in the clinical presentation of adult ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

A psychopathological study into the relationship between attention deficit hyperactivity disorder in adult patients and recurrent brief depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, mul

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Atomoxetine and Adult Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Hyperactive boys almost grown up. V. Replication of psychiatric status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Cognition in anxious children with attention deficit hyperactivity disorder: a comparison with clinical and normal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Characterizing cognition in ADHD: beyond executive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Patterns of Inattentive and Hyperactive Symptomatology in Cocaine-Addicted and Non-Cocaine-Addicted Smokers Diagnosed with Adult Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Gender and comorbid psychopathology in adolescents with alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

Managing ADHD in children, adolescents, and adults with comorbid anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

A clinical perspective of attention-deficit/hyperactivity disorder into adulthood

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

Attention deficit hyperactivity disorder in childhood among adults with major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

ADHD in adult psychiatric outpatients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

Young adult outcome of hyperactive children: adaptive functioning in major life activities

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900014036

7 January 2021

10.1017/S1092852900014036

Identifiers

DOI

1 reference

15 April 2018

1 reference

15 April 2018